Benzoic acid as a dietary supplement mitigates inflammation and intestinal dysfunction in acute ETEC-infected mice without adverse effects in healthy mice

Abstract

Benzoic acid is naturally occurring in fruits and is also commercially synthesized as an additive in the food, feed, and pharmaceutical industries. This study investigated the effects of benzoic acid as a dietary supplement on inflammation and intestinal integrity in acute ETEC-infected or healthy mice. Thirty-six BALB mice were allocated into 3 groups of 12 mice each for a 16-day feeding trial. Group 1 mice were fed basal diet, and 6 mice were sacrificed and 6 mice were intraperitoneally injected with PBS on day 15. Group 2 and 3 mice were fed basal diet and 0.6% benzoic acid diet, respectively, and half mice of each group were sacrificed and the others were intraperitoneally injected with ETEC on day 15. The results show that benzoic acid had no adverse effects on healthy mice regarding growth, organ indices, inflammation, intestinal morphology, barrier function, and caecal short-chain fatty acid levels. Importantly, benzoic acid reduced inflammation in ETEC-infected mice, as indicated by decreased serum IL-1β, TNF-α, and INF-γ levels and increased jejunal TLR-2 and MyD88 mRNA expression. Besides, benzoic acid enhanced intestinal function in ETEC-infected mice by increasing jejunal VH and VH/CD, elevating jejunal Occludin mRNA level, decreasing serum D-lactate and DAO levels, and increasing caecal acetic acid level. The16s rRNA sequencing shows that benzoic acid altered the β-diversity of ETEC-infected mice and increased the abundance of Erysipelotrichaceae, Faecalibaculum, and Turicibacter in their gut microbiota. The Spearman correlation analysis further reveals that the protective effects of benzoic acid against ETEC infection are closely linked to specific gut microbiota, namely Erysipelotrichaceae, Faecalibaculum, Bifidobacterium, and Limosilactobacillus. Collectively, benzoic acid could serve as a safe dietary supplement for healthy mice and can alleviate inflammation and intestinal dysfunction in mice with acute ETEC infection.

Article information

Article type
Paper
Submitted
26 Jan 2025
Accepted
23 Mar 2025
First published
24 Mar 2025

Food Funct., 2025, Accepted Manuscript

Benzoic acid as a dietary supplement mitigates inflammation and intestinal dysfunction in acute ETEC-infected mice without adverse effects in healthy mice

J. Chen, X. Jia, Y. Hu, X. Zhao, Y. Cheng, L. Lu, S. Zhong, J. You and T. Zou, Food Funct., 2025, Accepted Manuscript , DOI: 10.1039/D5FO00514K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements